作为新质生产力的代表，合成生物学、生物制造以及生物产业，近些年，受到来自政产学研用金各 方广泛关注和重点支持，多地政府将合成生物制造产业写进工作报告。 科学家、企业家和投资家， 在产业发展中发挥着重要作用。 融行业智慧、共襄盛举 聚产业力量、擘画未来 第三届SynBio Suzhou中国合成生物学"科学家+企业家+投资家"大会 将于2025年8月1-2日在 苏州 国际博览中心 举办（同期举办 第七届CMC-China博览会 ）！ 扫码！锁定免费参会名额！ 话题将覆盖： 农业、食品与能源， 医美、医药、大健康 ， 合成生物技术、中试放大与商业化， 以 及 项目路演 等多个方面，诚邀莅临，共襄盛举！ 常珊 往期精彩： 大会主办丨 Synbio深波 会议时间 | 2025年8月1-2日 会议地点 | 中国·苏州·国际博览中心B馆 扫码！锁定免费参会名额！ 圆满落幕！下一站去哪？2023中国（苏州）合成生物学创新峰会成功 举办 2023中国(苏州)合成生物学产业技术峰会圆满落幕 合成生物，聚势苏州：2024中国合成生物学"科学家+企业家+投资 家"大会圆满召开！ 往期嘉宾 阵容 (按首字母排序,排名不分先后，嘉宾单位 ...

一段时间以来，河北、上海等地发力促进政产学研用紧密结合，建立未来产业投入增长机制，培育生物 制造、量子科技、具身智能、6G等未来产业。眼下，生物制造凭借其先进的生产方式，成为未来科技 竞争的关键驱动力，在医药、农业、能源、环保等诸多领域发挥着日益重要的作用，成为推动经济高质 量发展的关键引擎。 数据显示，2024年我国生物制造市场规模突破2.8万亿元，较2020年增长267%，年复合增长率达 39.6%。其中，生物医药蓬勃发展，近5年来我国生物药品制造企业数量年均增长速度达12%，区域生物 制造发展亮点纷呈。例如，广州市集聚6500多家生物医药与健康领域企业，居全国前列；上海金山区 以"一核多点"的产业布局为引擎，在生物医药、生物材料、生物农业及健康食品等多个领域全面发力， 打造长三角生物制造创新高地。 相关政策支持体系日趋完善，为产业发展注入强劲动力。2022年出台的《扩大内需战略规划纲要（2022 —2035年）》明确提出，加快生物医药、生物农业、生物制造、基因技术应用服务等产业化发展。2024 年发布的《关于加快推动制造业绿色化发展的指导意见》提出，发挥生物制造选择性强、生产效率高、 废弃物少等环境友好 ...

Core Viewpoint - Shenzhen has introduced 32 policy measures to support the development of the pharmaceutical and medical device industries, aiming to create a complete industrial ecosystem covering basic research, clinical translation, production, and market application [1][2]. Policy Support - The measures focus on the entire chain of pharmaceutical and medical device development, including preclinical research, clinical trials, registration, production, and market promotion, with special support for emerging technologies such as "AI+" in pharmaceuticals, biomanufacturing, and rare disease drugs [2][3]. - Significant financial incentives are provided for innovative drug development, with rewards of up to 30 million yuan for successful clinical trials and market entry of class 1 innovative drugs [2]. AI and Biomanufacturing - Shenzhen aims to promote the application of artificial intelligence in biomanufacturing and drug development, focusing on drug target discovery, drug design, and safety analysis, while supporting the establishment of major public service platforms for AI in drug development [3]. Clinical Trial Efficiency - The establishment of the Greater Bay Area International Clinical Trial Center is prioritized to optimize clinical trial resources and processes, aiming to reduce the internal time for initiating clinical trials to within 25 weeks [4]. - The measures also include expanding the "Hong Kong-Macao Drug and Device Pass" to facilitate the import of urgently needed medical products [4]. Talent Acquisition - Shenzhen plans to implement a global talent recruitment program focusing on high-level professionals in cell and gene therapy, with innovative evaluation systems for clinical research talent linked to career advancement [5].

Core Viewpoint - The collaboration between Wanhua Chemical and the Biological Island Laboratory aims to drive innovation in biomanufacturing and biobased materials, positioning the companies as leaders in the industry [1][3]. Group 1: Partnership and Support - On May 6, Wanhua Chemical and the Biological Island Laboratory officially signed a partnership agreement focusing on biobased materials and other innovative fields [1]. - The collaboration was initially announced on April 16, with support from the Guangzhou Science and Technology Bureau, which pledged to provide necessary policy and resource services [3]. Group 2: Wanhua Chemical's Strategic Focus - Since 2017, Wanhua Chemical has been investing in synthetic biology, establishing a comprehensive platform that includes upstream gene engineering, enzyme engineering, fermentation engineering, and downstream separation and purification [4]. - The company is primarily focused on three areas: nutrition and health, daily chemical care, and fragrance and flavor, enhancing its portfolio of high-end fine chemicals [5]. Group 3: Innovations in Biobased Products - Wanhua Chemical has made significant advancements in biobased materials, having developed the world's first 100% biobased TPU material in 2022, along with other products such as biobased TPU, polylactic acid (PLA), biobased polyether products, biobased emulsions, and biodegradable films [6]. - On February 19, the company launched the world's first biobased 1,3-butanediol, which is applicable in moisturizers and solvents for products like serums, cleansers, and sunscreens [7]. Group 4: Future Directions and Industry Engagement - In its latest 2024 annual report, Wanhua Chemical highlighted its commitment to exploring cutting-edge fields such as synthetic biology to prepare for future industry developments [10]. - The company will participate in the 10th Biobased Conference and Exhibition in Shanghai from May 25-27, where it will showcase its high-performance biobased nylon elastomers and discuss product strategies [11].

Core Viewpoint - The article emphasizes the importance of scaling and cost-effectiveness in the bio-manufacturing industry to compete with traditional manufacturing sectors, particularly the chemical industry, and to achieve carbon neutrality goals [6][10][12]. Group 1: Key Elements of Bio-Manufacturing - Bio-manufacturing is positioned as a manufacturing sector that aims to replace traditional industries, particularly chemicals and inorganic materials [6][10]. - The success of high-tech industries relies heavily on research and development investments, which must be supported by companies possessing core technological capabilities [6][7]. - Intellectual property protection is crucial for fostering innovation and ensuring that companies can profit from their research investments [8][9]. - The supply of raw materials is a significant challenge, as bio-manufacturing must find reliable and stable sources of biomass that do not compete with food supplies [9][10]. Group 2: Resource Factors - Current bio-manufacturing resources primarily include food crops and biomass, with high-energy raw materials like palm oil and soybeans being expensive [13][17]. - Corn is the main raw material for bio-manufacturing globally, but its use in China is limited due to population pressures [17][19]. - The industry faces challenges in utilizing agricultural waste effectively, with many attempts resulting in commercial failures [17][19]. Group 3: Cost Factors - Selecting the right projects is essential to minimize trial and error costs in bio-manufacturing [20][22]. - The bio-manufacturing industry must compete with fossil fuels, and the energy density of bio-based materials is inherently lower than that of traditional chemical products [21][22]. - The cost structure of bio-manufacturing in China is competitive due to lower labor and investment costs compared to the US and Europe [28][30]. Group 4: Market Factors - New bio-manufactured products face significant market entry challenges, including user risk perceptions and complex value chains [31][33]. - The competition is not only from peers but also from established fossil fuel industries, which dominate market standards and decision-making processes [37][38]. - There are negative perceptions about bio-manufacturing being small-scale and high-cost, which can hinder investment and market acceptance [38][40]. Group 5: Recommendations for Bio-Manufacturing in Hainan - Companies should consider competitive energy solutions and the availability of raw materials when establishing bio-manufacturing projects in Hainan [48][49]. - The government should facilitate market access for bio-manufactured products to encourage early adoption and create demonstration cases [49][50].

Core Viewpoint - Synthetic biology, biomanufacturing, and the bio-industry have gained significant attention and support from various sectors, including government, academia, and investment, with many local governments incorporating synthetic biology manufacturing into their work reports [1] Group 1: Event Information - The 3rd SynBio Suzhou China Synthetic Biology "Scientists + Entrepreneurs + Investors" Conference is scheduled for August 1-2, 2025, at the Suzhou International Expo Center, alongside the 7th CMC-China Expo [3] - The conference will cover topics such as agriculture, food and energy, medical aesthetics, pharmaceuticals, health, synthetic biology technology, pilot scale-up, commercialization, and project roadshows [3] - The previous events, including the 2023 China (Suzhou) Synthetic Biology Innovation Summit and the 2024 China Synthetic Biology "Scientists + Entrepreneurs + Investors" Conference, were successfully held [3][25] Group 2: Participant Information - Notable past guests include experts from various institutions, such as Jiangsu University of Technology, Nanjing University of Technology, and Shanghai Jiao Tong University, highlighting the diverse expertise present at these events [4][6][7] - The participation of industry leaders and researchers indicates a strong collaborative effort in advancing synthetic biology and biomanufacturing [4][6][7] Group 3: Expo Details - The 7th CMC-China Expo is expected to attract 20,000 attendees, feature 450 exhibiting companies, and host 25 cutting-edge forums with 600 invited guests [15] - The expo will include multiple exhibition halls, focusing on raw materials, synthetic biology, CXO & MAH & DDS, pharmaceutical brands, and innovative drugs & biopharmaceuticals [15]

Core Viewpoint - Synthetic biology, biomanufacturing, and the bio-industry have gained significant attention and support from various sectors, including government, academia, and investment, with many local governments incorporating synthetic biological manufacturing into their work reports [1] Event Information - The 3rd SynBio Suzhou China Synthetic Biology "Scientists + Entrepreneurs + Investors" Conference will be held on August 1-2, 2025, at the Suzhou International Expo Center, alongside the 7th CMC-China Expo [3] - The conference will cover topics such as agriculture, food and energy, medical aesthetics, pharmaceuticals, health, synthetic biology technology, pilot scale-up, commercialization, and project roadshows [3] Previous Events - The 2023 China (Suzhou) Synthetic Biology Innovation Summit and the 2023 China (Suzhou) Synthetic Biology Industry Technology Summit were successfully concluded [3] - The 2024 China Synthetic Biology "Scientists + Entrepreneurs + Investors" Conference was also successfully held [3] Guest Lineup - Notable past guests include experts from various institutions and companies, such as Jiangsu University of Technology, Nanjing University of Technology, and Fuxing Ruizheng Capital, showcasing a diverse range of expertise in synthetic biology and biomanufacturing [4][5][6][7][8] Expo Scale and Structure - The 7th CMC-China Expo is expected to attract 20,000 attendees, feature 450 exhibiting companies, host 25 cutting-edge forums, and include 600 invited guests [15] - The expo will consist of four exhibition halls, including the raw materials and synthetic biology hall, CXO & MAH & DDS hall, pharmaceutical brand hall, and innovative drugs & biopharmaceuticals hall [15] Exhibition Opportunities - The synthetic biology hall (B hall) is open for companies involved in synthetic biology and modern biotechnology applications to register for exhibition space, providing opportunities for showcasing products and services [16]

Core Viewpoint - The establishment of the Synthetic Biology and Bio-Manufacturing Institute at Tianjin University marks a significant step in advancing synthetic biology education and research in China, aiming to respond to the challenges of the biotechnology revolution and the transformation of the bio-manufacturing industry [1][2][3]. Group 1: Strength in Synthetic Biology - Tianjin University has a strong foundation in synthetic biology, housing the National Key Laboratory of Synthetic Biology and the Ministry of Education's "Zhu Feng Plan" Frontier Science Center for Synthetic Biology, leading to a vibrant innovation team composed of academicians and national-level talents [2][3]. - The university has undertaken 34 national key research and development projects and has published the highest number of research papers in synthetic biology globally over the past three years [2][3]. Group 2: Goals for World-Class Discipline - The new institute aims to integrate multidisciplinary resources and leverage artificial intelligence to enhance teaching and research, creating a comprehensive talent cultivation and research innovation platform [3]. - The institute plans to achieve significant breakthroughs in forward-looking basic research and leading original results, producing key common technologies and disruptive innovations to support sectors such as healthcare, energy materials, biological breeding, and environmental governance [3]. - A dynamic adjustment mechanism for professional disciplines will be established, along with interdisciplinary courses and practical projects, fostering a cross-disciplinary learning and research environment for students [3].

Group 1 - In the first quarter of 2025, Guangzhou signed 677 new industrial investment projects with a total expected investment of 227.49 billion yuan, leading the province in domestic project investment volume and ranking second in growth rate [1] - Major projects include a 54.9 billion yuan direct current transmission project, a new company established by GAC Group with a registered capital of 1.5 billion yuan, and a 2.48 billion yuan automotive intelligent vision product headquarters in Nansha [1] - The city is also attracting significant investments in the biomanufacturing and artificial intelligence sectors, with projects from companies like Kasei Rui Biotech and Hikvision [1] Group 2 - Manufacturing is the core of the real economy in Guangzhou, with over 70% of investment in manufacturing projects in districts like Conghua, Panyu, and Huadu, and over 60% in Nansha and Zengcheng [2] - In the first quarter, Guangzhou conducted over ten overseas investment promotion trips to countries including Spain, Japan, and South Korea, attracting numerous multinational companies [2] - The city established 1,701 new foreign-funded projects in the first quarter, with actual foreign investment amounting to 10.78 billion yuan, showing a year-on-year increase of 1.1% [2] Group 3 - The French parent company of the Schenkend electronic measurement equipment project is a leader in X-ray thickness measurement technology, establishing a new production and R&D center in Guangzhou due to the favorable industrial environment [3]

作为新质生产力的代表，合成生物学、生物制造以及生物产业，近些年，受到来自政产学研用金各 方广泛关注和重点支持，多地政府将合成生物制造产业写进工作报告。 科学家、企业家和投资家， 在产业发展中发挥着重要作用。 融行业智慧、共襄盛举 扫码！锁定免费参会名额！ 话题将覆盖： 农业、食品与能源， 医美、医药、大健康 ， 合成生物技术、中试放大与商业化， 以 及 项目路演 等多个方面，诚邀莅临，共襄盛举！ 往期精彩： 聚产业力量、擘画未来 第三届SynBio Suzhou中国合成生物学"科学家+企业家+投资家"大会 将于2025年8月1-2日在 苏州 国际博览中心 举办（同期举办 第七届CMC-China博览会 ）！ 圆满落幕！下一站去哪？2023中国（苏州）合成生物学创新峰会成功举办 2023中国(苏州)合成生物学产业技术峰会圆满落幕 合成生物，聚势苏州：2024中国合成生物学"科学家+企业家+投资家"大会圆满召开！ 大会主办丨 Synbio深波 会议时间 | 2025年8月1-2日 会议地点 | 中国·苏州·国际博览中心B馆 扫码！锁定免费参会名额！ 往期嘉宾 阵容 (按首字母排序,排名不分先后，嘉宾单位或头衔为参 ...